Home  >  Products  >  TCL1B (T-cell leukemia/lymphoma 1B ) Blocking Peptide (the N terminal of TCL1B)(100ug)
TCL1B (T-cell leukemia/lymphoma 1B ) Blocking Peptide (the N terminal of TCL1B)(100ug)

TCL1B (T-cell leukemia/lymphoma 1B ) Blocking Peptide (the N terminal of TCL1B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TCL1B Antibody (ARP65206_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65206
Size: 100ug
Weight: 15kDa
Gene: 9623
Format: Lyophilized powder
Target: TCL1B enhances the phosphorylation and activation of AKT1 and AKT2.
Alternative names: TML1
See Full Product Listings >